Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer

Fig. 1

Knockdown of ADAMs and MMPs in human CRC cells. A HCT116 and HT29 cells were transfected with siADAM9, siADAM10, siADAM17, siADAM21, siMT1-MMP, siMMP2, siMMP9, or siCtrl; cell viabilities were determined by the CCK8 assay. B In HCT116 and HT29 cells, sMICA levels were determined by ELISA. *P < 0.05; **P < 0.005. Error bars represent standard error of the mean. Representative data from three independent experiments with consistently similar results are shown

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us